A Comprehensive Survey of Kinase Pathway Mutations in Poorly Differentiated Thyroid Carcinomas Using High-Throughput Mass Spectrometry-Based Genotyping
(480)
A Chitale, M Ryder, JCR Filho, J Knauff, M Ladanyi, J Fagin, R Ghossein - Henry Ford Hospital, Detroit, MI; Memorial Sloan Kettering Cancer Center, New York, NY
Absence of BRAF Mutation in HBME1 and CK19 Positive Atypical Cell Clusters in Hashimoto's Thyroiditis: Evidence Against Preneoplastic Change
(492)
MR Nasr, S Mukhopadhyay, S Zhang, A-LA Katzenstein - State University of New York Upstate Medical University, Syracuse, NY
Diagnostic Utility of Pax8 in Thyroid Epithelial Tumors with Special Emphasis on Anaplastic Carcinoma
(494)
D Nonaka, Y Tang, L Chiriboga, M Rivera, R Ghossein - New York University School of Medicine, and Memorial Sloan-Kettering Cancer Center, New York, NY
Thyroid Pathology in PTEN Hamartoma Tumor Syndrome: A Clinocopathologic and Molecular Genetic Analysis of a Distinctive Entity
(481)
J Dotto, H Kozakewich, V Nosé - Brigham and Women's Hospital, Boston, MA; Children's Hospital, Boston, MA
Diagnostic Utility of MicroRNA Profiling in Thyroid Fine Needle Aspiration Samples
(493)
MN Nikiforova, JE Dipaola, DL Steward, YE Nikiforov - University of Pittsburgh, Pittsburgh, PA; University of Cincinnati, Cincinnati, OH
Methylation Screening of Thyroid Cell Lines and Tissues
(505)
MD Williams, JP Issa, C Lu, GL Clayman, AK El-Naggar - M.D. Anderson Cancer Center, Houston, TX
Automated Quantitative Analysis of Claudin 1 as a Diagnostic Marker of Papillary Thyroid Carcinoma
(486)
TJ Giordano, D Sanders, R Koenig, Y Nikiforov, DG Thomas - University of Michigan, Ann Arbor, MI; University of Pittsburgh, Pittsburgh, PA
The Incidence of Occult Papillary Thyroid Carcinomas in Patients with Benign Thyroid Nodules
(504)
MD Williams, JW Suliburk, GA Staerkel, NL Busaidy, JE Lee, GL Clayman, DB Evans, ND Perrier - M.D. Anderson Cancer Center, Houston, TX; University of Texas, Houston, TX
PPARD Is Over Expressed in Thyroid Tumors and Regulates Proliferation in Primary Thyroid Cells
(507)
L Zeng, M Tretiakova, X Yu, P Michalewicz, TG Kroll - University of Chicago School of Medicine, Chicago, IL
Animal Model for Bevacizumab (Anti-VEGF Antibody) Therapy for Human Endocrine Tumors: Targeted Inhibitory Effect of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-Induced Pituitary Prolactinoma in Fischer 344 Rats
(490)
K Miyajima, S Takekoshi, T Miyakoshi, J Ito, H Kajiya, N Egashira, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan
Immunohistochemical Expression of Notch Molecules in Human Pituitary Adenomas: Their Relationship with Subtypes of Adenomas
(483)
N Egashira, S Takekoshi, M Takei, A Teramoto, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan; Nippon Medical School, Tokyo, Japan
Reduced Expression of the let-7 microRNAs in Human Pituitary Adenomas Is Associated with Pituitary Tumorigenesis through Up-Regulating HMGA2 Expression
(495)
ZR Qian, T Sano, YF Yuan, SL Asa, S Yamada, E Kudo - Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan; University of Toronto, Toronto, ON, Canada; Toranomon Hospital, Tokyo, Japan
Immunohistochemical Expression of Parafibromin Is of Limited Value in Distinguishing Parathyroid Carcinoma from Adenoma
(489)
S Mangray, KC Kurek, E Sabo, RA DeLellis - Rhode Island Hospital, Providence, RI; Children's Hospital, Boston, Boston, MA
Expression of Parafibromin in Parathyroid Carcinoma in Advanced Secondary Hyperparathyroidism Patients Due to Chronic Kidney Disease
(503)
T Tsuzuki, Y Tominaga, S Matsuoka, N Uno, T Sato, S Shimabukuro, N Goto, T Nagasaka, K Uchida, N Maeda - Nagoya Daini Red Cross Hospital, Nagoya, Japan
Retroperitoneal Paraganglioma, 70 Cases: Attempt to Histologically Predict Malignant Behavior
(484)
JC Fanburg-Smith, A Auerbach, CS Heffess - Armed Forces Institute of Pathology, Washington, DC
Increased Insulin-Like Growth Factor II and IGF1 Receptor Alpha Expression in Pancreatic Islets of Adult Patients with Post-Gastric Bypass Surgery Nesidioblastosis
(497)
KM Rumilla, LA Erickson, FJ Service, GB Thompson, RV Lloyd - Mayo Clinic, Rochester, MN
Loss of O6-Methyl-Guanine-Methyl-Transferase (MGMT) Immunoreactivity Is a Predictor of Poor Survival in Pancreatic Endocrine Tumors (PET)
(498)
AM Schmitt, M Anlauf, S Schmid, T Rudolph, Y Jonkers, EJ Speel, H Moch, P Komminoth, A Perren - University Hospital Zurich, Zurich, Switzerland; City Hospital Triemli, Zurich, Switzerland; TUM, Munich, Germany; University of Maastricht, Maastricht, Netherlands; University of Kiel, Kiel, Germany
button next to any title to add to Itinerary Planner...
Add
